Psoriasis Biologics Guidelines and Care Improvement Strategies
Resident's Online Coding Education
Basic Dermatology Curriculum ( 2-Week Rotation)
Basic Dermatology Curriculum (3-Week Rotation) for Internists
Basic Dermatology Curriculum (3-Week Rotation) for Pediatricians
Basic Dermatology Curriculum (4-Week Rotation)
Basic Dermatology Curriculum (All Modules)
Basic Dermatology Curriculum (Videos)
Cutaneous Lupus Erythematosus and Dermatomyositis
Morphea and Systemic Sclerosis
Hands on at Home: Dermatology Suture Techniques
Managing Co-Morbidities Associated with Psoriasis and Care Improvement Strategy
Prior Authorization: What a Pain!
Autoimmune Connective Tissue Disease and Vasculitis Education Program
Boards Fodder Flashcards (Sample Pack)
2021 - eCompliance Series - HIPAA Training for Medical Office Module
2021 - eCompliance Series - OSHA Training for Medical Office Module
2021 - eCompliance Series - Preparing for the CLIA Inspection Module
Board Prep Plus
Clinical Photography for Skin of Color
Introduction to Quality Improvement and Patient Safety in Dermatology: Phototherapy
Skin of Color Curriculum
Essentials of Pediatric Dermatology - Online Module
Teledermatology and COVID-19 Survey
Dialogues in Dermatology: Severe Cutaneous Adverse Reactions
Dialogues in Dermatology: Dermatologic Side Effects of Anticancer Drugs in 2020: What You Need To Know
Dialogues in Dermatology: Diagnostic Errors and Lessons From Medical Dermatology Referrals
Dialogues in Dermatology: Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
Dialogues in Dermatology: Controversies and Difficult Questions Concerning Biologic Therapeutics
Dialogues in Dermatology: JAAD Game Changers: Oral Tranexamic Acid (TA) in the Treatment of Melasma: A Retrospective Analysis
Dialogues in Dermatology: How Far Can We Get With Medical Imaging?
Dialogues in Dermatology: LGBTQ/SGM Health in Dermatology: Essentials and Updates
Dialogues in Dermatology: What To Do When Patch Testing is Negative
Dialogues in Dermatology: Chronic Urticaria and Angioedema: What’s New in Pathogenesis and Treatment
Dialogues in Dermatology: Machine Learning in Dermatology
Dialogues in Dermatology: Alternative/Complementary Medicine Related to Derm Conditions
Dialogues in Dermatology: New and Emerging Therapies: Itch
Dialogues in Dermatology: Hair Loss in Women 2021 Update
Dialogues in Dermatology: What’s New in Energy-Based Devices
Dialogues in Dermatology: Meditation/Stress Relief and Dermatologic Conditions
Dialogues in Dermatology: Inflammatory Skin Diseases: The Translational Revolution
Dialogues in Dermatology: What’s New in Blistering Diseases, Diagnostics
Dialogues in Dermatology: Melanoma Monday: What’s New in Melanoma?
Dialogues in Dermatology: Creative Therapeutics for Recalcitrant Dermatoses
Dialogues in Dermatology: Therapeutic Uses of Botulinum Toxin
Dialogues in Dermatology: Diversity in the Dermatologic Workplace
Dialogues in Dermatology: New Advances in CCCA
Dialogues in Dermatology: New Advances in Melasma
Dialogues in Dermatology: Off-Label Uses for Botulinum Toxin
Dialogues in Dermatology: New Advances in Cellulite Treatment
Dialogues in Dermatology: Male Genital Dermatology: Lessons Learned From a Male Genital Skin Disease Clinic
Dialogues in Dermatology: Vulvar Dermatology
Dialogues in Dermatology: Lichen Planus
Dialogues in Dermatology: Skin Conditions in Down Syndrome
Dialogues in Dermatology: Solving the Genetic Syndrome Puzzle
Dialogues in Dermatology: Cutting Edge Multidisciplinary Care of the CTCL Patient
Dialogues in Dermatology: Addressing Unmet Needs in Diverse Populations: Therapeutic, Aesthetic, and Investigational Approaches
Dialogues in Dermatology: Approach to pigmented lesions
Dialogues in Dermatology: Atypical Leg Ulcers
Dialogues in Dermatology: Avoiding Complications and Maximizing Results in Laser Surgery
Dialogues in Dermatology: Caring for the Cancer Patient: Updates in Cutaneous Oncology
Dialogues in Dermatology: Clinical Research
Dialogues in Dermatology: Clinical Trials in Dermatology
Dialogues in Dermatology: Comprehensive Approach to Neuromodulators and Fillers
Dialogues in Dermatology: Cosmetic Concerns and Considerations
Dialogues in Dermatology: Dermatologic Care of Refugee Populations
Dialogues in Dermatology: Dermoscopy-Learning from Easy and Difficult Cases
Dialogues in Dermatology: Dietary Triggers and Modifications of Common Dermatologic Conditions
Dialogues in Dermatology: Do I Order the ANA By Multiplex or IFA
Dialogues in Dermatology: Dysplastic Nevi for Dummies
Dialogues in Dermatology: Emerging New Therapies
Dialogues in Dermatology: Ethics in Dermatology
Dialogues in Dermatology: Functional Genomics
Dialogues in Dermatology: Global Health Dermatology
Dialogues in Dermatology: Graft Versus Host Disease
Dialogues in Dermatology: Great Cases from Safety Net Hospitals
Dialogues in Dermatology: Hair Disorders Made Easier
Dialogues in Dermatology: Hidradenitis Suppurativa
Dialogues in Dermatology: High Risk Squamous Cell Carcinoma
Dialogues in Dermatology: Hit Me With Your Best Shot
Dialogues in Dermatology: Inpatient Consultative Dermatology
Dialogues in Dermatology: Itch
Dialogues in Dermatology: Keloids
Dialogues in Dermatology: Lessons in CPC: Learning from Diagnostic Errors in Dermatopathology
Dialogues in Dermatology: Lichen Planus and Lichen Planopilaris
Dialogues in Dermatology: Managing Non-Melanoma Skin Cancer in Very Elderly Patients
Dialogues in Dermatology: Nails
Dialogues in Dermatology: New and Emerging Therapies with Platelet-Rich Plasma
Dialogues in Dermatology: Patch Testing
Dialogues in Dermatology: Patient Voice Pemphigus Vulgaris
Dialogues in Dermatology: Physician Burnout
Dialogues in Dermatology: Pigmented Lesions
Dialogues in Dermatology: Pigmented Potpourri – How To Evaluate, Diagnose, and Treat Pigmentary Conditions
Dialogues in Dermatology: Practical Management of Birthmarks and Hamartomas
Dialogues in Dermatology: Practical to Cutting Edge: How to Care for our CTCL Patients
Dialogues in Dermatology: Professionalism in Dermatology
Dialogues in Dermatology: Psoriasis: Advances in Comorbidities and Therapy
Dialogues in Dermatology: Public Health & Dermatology
Dialogues in Dermatology: Skin of Color Boot Camp 8.24.20
Dialogues in Dermatology: Skin of Color Through the Ages
Dialogues in Dermatology: Skin Related to the Immune Checkpoint Inhibitors
Dialogues in Dermatology: Staying General in Dermatology
Dialogues in Dermatology: The Changing Landscape of Early Stage Melanoma Management
Dialogues in Dermatology: The Revamped Morbidity and Mortality
Dialogues in Dermatology: What’s New in Acne
Dialogues in Dermatology: What’s New in Wound Care
Dialogues in Dermatology: What's That? Syndrome Update
Dialogues in Dermatology: Women’s Health Therapeutic Hotline
Question of the Week Self-Assessment - 2021
Dialogues in Dermatology: Off-Label Use of Biologics and New Medications
Dialogues in Dermatology: Alopecia Areata
Dialogues in Dermatology: JAAD Game Changer: Standardized Laboratory Monitoring with Use of Isotretinoin in Acne
Dialogues in Dermatology: Body Dysmorphic Disorder
Dialogues in Dermatology: What’s New in Blistering Diseases, Therapeutics
Dialogues in Dermatology: Soft Tissue Augmentation and Neurotoxins in Patients of Skin of Color
Dialogues in Dermatology: Keloidal and Hypertrophic Scarring
Dialogues in Dermatology: Pearls for Surveillance and Management of High-Risk Skin Cancer Patients
Dialogues in Dermatology: Scars: What Have We Learned and Where are We Going?
Dialogues in Dermatology: Hand and Foot Psoriasis, Dermatitis and Other Inflammatory Dermatoses
Dialogues in Dermatology: Pigmentary Disorders: Longitudinal Melanonychia
Dialogues in Dermatology: Advances in the Treatment of Androgenetic Alopecia: Part I
Dialogues in Dermatology: Severe Exacerbations/Inpatient Presentation of Common Dermatoses
Dialogues in Dermatology: Updates in Hair Disorders
Dialogues in Dermatology: What’s New in the Pediatric Dermatology Toolbox
Dialogues in Dermatology: What’s New In Skin of Color
Dialogues in Dermatology: Where Do We Stand? The Pathogenesis and Treatment of Melasma
Dialogues in Dermatology: Psychodermatology
Dialogues in Dermatology: Phototherapy for Psoriasis in the Age of Biologics
Dialogues in Dermatology: Systemic Sclerosis
JAAD 1/21 Reflectance Confocal Microscopy. Diagnostic criteria of common benign and malignant neoplasms, dermoscopic and histopathologic correlates of key confocal criteria, and diagnostic algorithms
JAAD 1/21 Reflectance confocal microscopy: Principles, basic terminology, clinical indications, limitations, and practical considerations
JAAD 2/21 Pediatric Allergic Contact Dermatitis. Part I. Clinical Features and Common Contact Allergens in Children
JAAD 2/21 Pediatric Allergic Contact Dermatitis. Part II. Patch Testing Series, Procedure, and Unique Scenarios
JAAD 3/21 The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication
JAAD 3/21 The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part II, Current and Future Approaches
JAAD 04/21: Preventing complications in dermatologic surgery: Presurgical concerns
JAAD 04/21 Preventing and managing complications in dermatologic surgery: Procedural and postsurgical concerns
JAAD 5/21 Visible Light Part I. Properties and Cutaneous Effects of Visible Light
JAAD 5/21 Visible Light Part II. Photoprotection against visible and ultraviolet light
JAAD 6/21 Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis
JAAD 6/21 Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy
JAAD 7/21 Subepidermal Autoimmune Blistering Dermatoses: Clinical Features and Diagnosis
JAAD 7/21 Subepithelial Autoimmune Bullous Dermatoses Disease Activity Assessment and Therapy
JAAD 8/21 In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests
JAAD 8/21 In-Vitro Diagnostics for the Medical Dermatologist: Part 2: Hypercoagulability Tests
JAAD 9/21 Radiation therapy in the treatment of cutaneous malignancies. Part I: Diagnostic modalities and applications
JAAD 9/21 Radiation therapy in the treatment of cutaneous malignancies. Part II: Indications, efficacy, safety
JAAD 10/21 Part I. Hair Transplantation: Basic Overview
JAAD 10/21 Part II. Hair Transplantation: Surgical Technique
JAAD 11/21 Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome – Part I: Clinical and histologic features and diagnosis
JAAD 11/21 Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome. Part II: Prognosis and Management
JAAD 12/21 Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment.
JAAD 12/21 Infantile hemangioma. Part 2: Management
JAAD 01/20 Sexually acquired syphilis: Historical aspects, microbiology, epidemiology, and clinical manifestations
JAAD 01/20 Sexually acquired syphilis: Laboratory diagnosis, management, and prevention
JAAD 02/20 Dermatomyositis Part I: Clinical Features and Pathogenesis
JAAD 02/20 Dermatomyositis: Diagnosis and Treatment
JAAD 03/20 Ectoparasites: Scabies
JAAD 03/20 Pediculosis and tungiasis
JAAD 04/20 Retiform purpura: A diagnostic approach
JAAD 04/20 Retiform purpura: Workup and therapeutic considerations in select conditions
JAAD 05/20 Hidradenitis suppurativa: Current and emerging treatments
JAAD 05/20 Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis
JAAD 06/20 Vulvar diseases: Approach to the Patient
JAAD 06/20 Vulvar diseases: Conditions in adults and children
JAAD 07/20 Leprosy: Clinical aspects and diagnostic techniques
JAAD 07/20 Leprosy: Treatment and Management of Complications
JAAD 08/20 Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with lupus erythematosus
JAAD 08/20 Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with morphea/systemic sclerosis
JAAD 09/20 Field Cancerization: Definition, epidemiology, risk factors, and outcomes
JAAD 09/20 Field Cancerization: Treatment
JAAD 10/20 Technological advances for the detection of melanoma Part I. Advances in imaging techniques
JAAD 10/20 Technological advances for the detection of melanoma Part II. Advances in molecular techniques
JAAD 11/20 Part I: Immune checkpoint inhibitors to treat cutaneous malignancies
JAAD 11/20 Part II: Immune checkpoint inhibitor-related dermatologic adverse events
JAAD 12/20 Prurigo Nodularis: Epidemiology and Clinical Features
JAAD 12/20 Prurigo Nodularis: Pathogenesis and Management
JAAD 12/19 Visual perception, cognition, and error in dermatologic diagnosis
JAAD 12/19 Visual perception, cognition, and error in dermatologic diagnosis: Part 2
JDCR Case Challenge - January 2021
JDCR Case Challenge - February 2021
JDCR Case Challenge - March 2021
JDCR Case Challenge - April 2021
JDCR Case Challenge - May 2021
JDCR Case Challenge - June 2021
JDCR Case Challenge - July 2021
JDCR Case Challenge - August 2021
JDCR Case Challenge - January 2020
JDCR Case Challenge - February 2020
JDCR Case Challenge - March 2020
JDCR Case Challenge - April 2020
JDCR Case Challenge - May 2020
JDCR Case Challenge - June 2020
JDCR Case Challenge - July 2020
JDCR Case Challenge - August 2020
JDCR Case Challenge - September 2020
JDCR Case Challenge - October 2020
JDCR Case Challenge - November 2020
JDCR Case Challenge - December 2020
JDCR Case Challenge - December 2019
JDCR Case Challenge - September 2021
JDCR Case Challenge - October 2021
JDCR Case Challenge - November 2021
JDCR Case Challenge - December 2021
Dialogues in Dermatology: Surgical Anatomy of the Head and Neck
Dialogues in Dermatology: Nail Surgical Techniques Made Simple
Dialogues in Dermatology: Pearls in Reconstruction
Dialogues in Dermatology: Lasers and Light Sources
Core Curriculum
Ethical Dilemmas in Dermatology
Dialogues in Dermatology: Facial Anatomy Danger Zones
Question of the Week Self-Assessment - 2022
JAAD 01/22 Itch: epidemiology, clinical presentation, and diagnostic workup
JAAD 01/22 Itch: pathogenesis and treatment
JDCR Case Challenge - January, 2022
Dialogues in Dermatology: Skin Conditions in Asian Patients That You Do Not Want to Miss
JAAD Manuscript Review 2022
Dialogues in Dermatology: Allergic Contact Dermatitis
Vasculitis
Dialogues in Dermatology: Comorbidities and Psoriasis
Dialogues in Dermatology: JAAD Game Changer: Comparative Effectiveness of Biologic Agents for the Treatment of Psoriasis in a Real-World Setting: Results from a Large, Prospective, Observational Study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Dialogues in Dermatology: Advances in Treatment of Androgenetic Alopecia: Part II
Dialogues in Dermatology: Practice with a Purpose and Never Burn Out
JAAD 02/22 The Epidemiology, Impact, and Diagnosis of Micronutrient Nutritional Dermatoses Part 1: Zinc, Selenium, Copper, Vitamin A, and Vitamin C
JAAD 02/22 The Epidemiology, Impact, and Diagnosis of Micronutrient Nutritional Dermatoses Part 2: B-Complex Vitamins
Dialogues in Dermatology: Malignant Melanoma: Molecular Diagnostics, Emerging Therapies, and the Microbiome
Dialogues in Dermatology: Acute and Chronic Pain Management in Dermatology
JAAD 03/22 Melanoma: How and When to Consider Clinical Diagnostic Technologies
2022 - eCompliance Series - HIPAA Training for Medical Office Module
2022 - eCompliance Series - OSHA Training for Medical Office Module
JAAD 03/22 Melanoma: An Update on Systemic Therapies
Dialogues in Dermatology: New Common Allergens in Personal Care Products
Dialogues in Dermatology: Oncodermatology
JDCR Case Challenge - February, 2022
Dialogues in Dermatology: Sclerotherapy Update and Review
JDCR Case Challenge - March, 2022
JAAD 04/22 An Update on Cosmetic Procedures in People of Color Part 1: Scientific background, assessment, pre-procedure preparation
JAAD 04/22 An Update on Cosmetic Procedures in People of Color Part 2: Neuromodulators, Soft Tissue Augmentation, Chemexfoliating Agents, and Laser Hair Reduction
JAAD 05/22 Calciphylaxis: Diagnosis and Pathology
JAAD 05/22 Calciphylaxis: Treatment and Outlook
Dialogues in Dermatology: FISH and CGH in Melanocytic Lesions
Dialogues in Dermatology: Non-Invasive Imaging in Dermatology
Dialogues in Dermatology: Mast Cell Diseases
Dialogues in Dermatology: What You Should Know About Management of High-Risk Squamous Cell Carcinoma
Psoriasis Phototherapy Guidelines and Care Improvement Strategies
Career Launch Boot Camp Collection
JDCR Case Challenge April, 2022
Dialogues in Dermatology: Fractionated Non-Ablative and Ablative Lasers in Skin of Color
Dialogues in Dermatology: New Topical Therapies for Psoriasis
2022 - eCompliance Series - Preparing for the CLIA Inspection Module
JAAD 06/22 Part I: Antimicrobial resistance: bacterial pathogens of dermatologic significance and implications of rising resistance
JAAD 06/22 Antimicrobials and Resistance: Update for the Dermatologist (Part II: Antifungals, Antivirals, and Antiparasitics)
Dialogues in Dermatology: JAK Inhibitors
Dialogues in Dermatology: Rosacea Classification, Comorbidities and Therapeutics 2022
Dialogues in Dermatology: What’s New in the Treatment of Hidradenitis Suppurativa
JAAD 07/22 Emerging Therapeutics in the Management of Connective Tissue Disease. Part I. Lupus Erythematosus and Sjögren’s Syndrome
JAAD 07/22 Emerging Therapeutics in the Management of Connective Tissue Disease. Part II. Dermatomyositis and Scleroderma
Dialogues in Dermatology: Melanoma Literature Update
Dialogues in Dermatology: Treatment of Moderate to Severe Rosacea
Dialogues in Dermatology: High Yield Tips for Care of Afro-Textured Hair
Dialogues in Dermatology: What's New in the Treatment of Warts?
Dialogues in Dermatology: GVHD
JAAD 08/22 Skin Cancer: Primary, Secondary, and Tertiary Prevention. Part I
JAAD 08/22 Skin Cancer: Primary, Secondary, and Tertiary Prevention. Part II
Dialogues in Dermatology: Rare Non-Melanoma Skin Cancer
Dialogues in Dermatology: In Office Radiation Treatment
JAAD 09/22 Cutaneous Manifestations of Child Abuse and Neglect: Part I
JAAD 09/22 Cutaneous mimics of child abuse and neglect: Part II
Dialogues in Dermatology: JAAD Game Changer: Dermoscopy of Black Skin
Dialogues in Dermatology: Understanding the Skin Barrier
Dialogues in Dermatology: Platelet-Rich Plasma
Dialogues in Dermatology: Herpes Zoster and Its Vaccine Nuances
Dialogues in Dermatology: Filler Rheology
Dialogues in Dermatology: Dermatologic Care for the Leukemia and Lymphoma Patient
Dialogues in Dermatology: Frontal Fibrosing Alopecia/Lichen Planopilaris
JAAD 10/22 Racial/Ethnic Health Disparities in Dermatology in the United States Part 1: Overview of Contributing Factors and Management Strategies
JAAD 10/22 Racial/Ethnic Health Disparities in Dermatology in the United States Part 2: Disease-specific Epidemiology, Characteristics, Management, and Outcomes
Dialogues in Dermatology: Gene Expression Profiling for Pigmented Lesions
Dialogues in Dermatology: Common Rare Tumors in Dermatology: Sebaceous Carcinoma, DFSP, EMPD—Diagnostic and Management Considerations
Dialogues in Dermatology: Appropriate Use Criteria in Dermatopathology: What Do They Mean for Dermatology?
JAAD 11/22 Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
JAAD 11/22 Systemic sclerosis in adults. Part II: Management and therapeutics
Dialogues in Dermatology: Acquired Dermal Macular Pigmentation: Where Do We Stand?
Dialogues in Dermatology: Advanced Therapeutics for Melanoma
Dialogues in Dermatology: New Medications Used in Primary Care and Their Dermatologic Side Effects
JAAD 12/22 Variations in Genetics, Biology, and Phenotype of Cutaneous Disorders in Skin of Color. Part I: Genetic, Biological, and Structural Differences in Skin of Color
JAAD 12/22 Variations in Genetics, Biology, and Phenotype of Cutaneous Disorders in Skin of Color. Part II: Differences in Clinical Presentation and Disparities in Cutaneous Disorders in Skin of Color
Dialogues in Dermatology: Skin Microbiome
Dialogues in Dermatology: Cell Transplant in Vitiligo
Dialogues in Dermatology: Vaccinations
Dialogues in Dermatology: Diseases of the Oral Mucosa
Dialogues in Dermatology: Home Use Devices – Sorting Out What Works
Dialogues in Dermatology: Getting the Most Out of Your Biopsies
Dialogues in Dermatology: Steroid Side Effects
Dialogues in Dermatology: High-Risk SCC Workup/Management
ABD_Question_Writing_Guide

PDF
AAD Learning Center Orientation Video